Gopalakrishnan, R., Matta, H., Tolani, B., Triche, T., & Chaudhary, P. M. (2015). Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors. Oncogene.
Stile di citazione ChicagoGopalakrishnan, Ramakrishnan, Hittu Matta, Bhairavi Tolani, Tim Triche, e Preet M. Chaudhary. "Immunomodulatory Drugs Target IKZF1-IRF4-MYC Axis in Primary Effusion Lymphoma in a Cereblon-dependent Manner and Display Synergistic Cytotoxicity With BRD4 Inhibitors." Oncogene 2015.
Citazione MLAGopalakrishnan, Ramakrishnan, et al. "Immunomodulatory Drugs Target IKZF1-IRF4-MYC Axis in Primary Effusion Lymphoma in a Cereblon-dependent Manner and Display Synergistic Cytotoxicity With BRD4 Inhibitors." Oncogene 2015.